Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C-Reference-Cited by-同舟云学术

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C

Published:2007-11-20 Issue:0 Volume:0 Page:071121030748004-???
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Komiya Yutaka,Katayama Keiko,Yugi Hisao,Mizui Masaaki,Matsukura Harumichi,Tomoguri Tetsushi,Miyakawa Yuzo,Tabuchi Ayako,Tanaka Junko,Yoshizawa Hiroshi

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2007.01522.x/fullpdf

Reference22 articles.

1. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis

2. Posttransfusion Fulminant Hepatitis B Associated with Precore-Defective HBV Mutants

3. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

4. Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA

5. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?;Journal of Viral Hepatitis;2024-08-10

2. Marked reduction in the incidence of transfusion‐transmitted hepatitis B virus infection after the introduction of antibody to hepatitis B core antigen and individual donation nucleic acid amplification screening in Japan;Transfusion;2023-09-28

3. Infectivity of hepatitis B virus (HBV) surface antigen (HBsAg) positive plasma with undetectable HBV‐DNA: Can HBsAg screening be discontinued in Egyptian blood donors?;Journal of Viral Hepatitis;2022-03-17

4. Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors;Antiviral Research;2021-12

5. Residual risk of transfusion‐transmitted hepatitis B virus ( TT‐HBV ) infection by NAT ‐screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections;Transfusion;2021-09-29